No Data
List of cloud break stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud break stocks]
○ List of Stocks Under the Cloud Market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <1663> K&O Energy 3120 3342.75 3290 <1721> Comsys HD 3187 3255.25 3212.5 <1786> Oriental Shiraishi 3823 387.5 382.5 <1835> Tohtetsu 3235 3240 3250 <1939> Shikoku Electric Construction 1408 1540.25
The Nikkei average fell by 172 points, dropping for the first time in four days, with a stronger yen weighing down, but many Main Board stocks rose = 7 days before the market.
Seven days ago, the Nikkei average stock price fell by 172.88 yen compared to the previous day, reaching 38,893.65 yen, marking a decline for the first time in four days. The TOPIX (Tokyo Stock Price Index) dropped by 10.61 points to 2,741.59 points. With the backdrop of a stronger yen, selling was dominant from the morning, and at 9:27 AM, the price reached 38,753.20 yen, down 313.33 yen. Subsequently, there was a movement to buy on dips, which reduced the decline. In the Foreign Exchange market, the yen strengthened to below 151 yen per dollar at one point, but later returned to 151 yen.
Volume change rate ranking (10 o'clock) - Technos JPN, Ribomic, ETC are ranked.
In the Volume change rate ranking, by comparing the latest 5-day average Volume and the Volume on the delivery day, one can understand the trends in stock selection and the interests of market participants. ■ Top Volume Change Rates [As of February 7, 10:32] (Comparison of latest 5-day average Volume) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <3666> Technos JPN 2979800 92259347.81% 0.015% <4591> Ribomic
Nippon Steel, operating profit for the third quarter decreased by 8.5% to 566.1 billion yen.
Nippon Steel <5401> announced its third quarter results for the fiscal year ending March 2025, reporting revenue of 6 trillion 552.4 billion 98 million yen, a 1.3% decrease compared to the same period last year, and an operating profit of 566.1 billion 25 million yen, an 8.5% decrease. For the fiscal year ending March 2025, revenue is planned to be 8 trillion 600 billion yen, a 3% decrease from the previous period. Additionally, the company announced the dissolution of its mutual investment relationship with Kobe Steel <5406>, which has continued since 2002, while business collaborations will continue. A review of the relationship of group companies and policy measures is underway.
Fuji Pharma: Summary of Financial Results for the 1st Quarter Ending 2025/9 [Japanese GAAP] (Consolidated)
Fuji Pharma Sees 1H Net Y1.65B